3579 results for «428»

Filter By

3579 results

TAVI basics Co-Medicals - in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session in japanese to learn more about the roles of co-medicals (before and after procedure), the decision-making and strategies prior to TAVI, and the management of comorbidities post TAVI.

TAVI basics Co-Medicals - in Japanese

PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.

STEMI interventions: First-in-Man and novel pharmacological strategies

Physiology or intracoronary imaging; or both? or none? - part 1

27 Jun 2020 – From PCR e-Course 2020

Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.

Physiology or intracoronary imaging; or both? or none?

PCR e-Course 2020 Hot line: left atrial appendage closure

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.

PCR e-Course Hot lines: left atrial appendage closure

Physiology or intracoronary imaging; or both? or none? - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.

Physiology or intracoronary imaging; or both? or none?

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

PCR e-Course Hot lines on TAVI – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.

Hotlines on TAVI

Hot lines on tricuspid interventions

Watch a series of Hot Lines on repair techniques for tricuspid regurgitation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Transferomal TTVR with EVOQUE, STTAR, TRILUMINATE.

Hot lines on tricuspid interventions

Aortic Valve Thrombosis

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.

Aortic Valve Thrombosis

Shared decision making in low-risk patients with aortic stenosis

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.

Shared decision making in low-risk patients with aortic stenosis

Strategies to handle complications during interventions for structural heart disease: my worst nightmare - Part 1

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn all about how to handle and avoid complications during interventions for structural heart disease, such as TAVI valve emboli, intra-aortic balloon occlusion, mitral leaflet tear, and more!

Strategies to handle complications during interventions for structural heart disease

MitraClip and challenging anatomies

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn from a selection of challenging Mitraclip cases, how to avoid and cope with various complications, such as single-leaflet device attachment and leaflet tear, mitral stenosis, chordal entanglement, and more!

MitraClip and challenging anatomies

Troubleshooting transcatheter aortic valve implantation (TAVI) for common complications: my worst nightmare - Part 2

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about how to provide practical troubleshooting on transcatheter aortic valve implantation (TAVI) for common complications, such as annulus rupture, aortic rupture and ischemic stroke, and get insight into the pre-procedural planning to prevent these complications.

Troubleshooting transcatheter aortic valve implantation (TAVI) for common complications

Mitral and tricuspid valves: new technologies on the horizon

16 Feb 2020 – From PCR Tokyo Valves 2020

Learn about up-to-date data regarding new mitral and tricuspid percutaneous techniques and future repair technologies...

Mitral and tricuspid valves: new technologies on the horizon
Didn’t find what you were looking for?